NDC 16729-549 – BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE

Buprenorphine Hydrochloride 2 mg/1; Naloxone Hydrochloride Dihydrate .5 mg/1 · Tablet · Sublingual

Human Prescription Drug DEA schedule CIII

Product NDC16729-549

Product details

Brand name
BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE
Generic name
BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE
Labeler
Accord Healthcare, Inc
Dosage form
Tablet
Route
Sublingual
Marketing category
ANDA · ANDA209069
Marketed since
September 1, 2020
Listing expires
December 31, 2026
Pharmacologic class
Opioid Antagonist; Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE →

Package NDC codes (1)

Package NDCDescriptionSince
16729-549-1030 TABLET in 1 BOTTLE, PLASTIC (16729-549-10)Sep 1, 2020

Other BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE products